- Stocks
- Healthcare
NMTC
NeuroOne Medical Technologies Corporation
NMTC
NASDAQ·Healthcare·Medical - Devices·Mkt cap $14.1M
$1.06
▲ +2.91%
P/E
-1.25
Mkt Cap
$14.1M
52-Wk Range
$1.01–$6.96
52-Week Range
$1.01 - $6.96
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 80.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary thin film electrode technology enabling simultaneous recording and ablation
- Strategic partnership with RBC Medical Innovations for advanced ablation systems
- Focused expertise in underserved neurological disorder markets
- Innovation in minimally invasive neurotech solutions
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Strong growth ahead
Rising prevalence of epilepsy and neurological disorders globally
Value
Deep value opportunity - significant discount to sector peers
Momentum
Falling
-65.7% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying NMTC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Dec 15, 2026
AUG 13, 2026
Reported EPS of -$0.28 vs -$0.21 consensus (-33.3% surprise). Revenue of $2.0M vs $2.2M expected (-8.9%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-33.3%
Revenue trend · last 8Q
—
—
—
+1%
+105%
+907%
-12%
+16%
Q3 24
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
Q3 26
$825.8K
$272.3K
$3.3M
$1.4M
$1.7M
$2.7M
$2.9M
$2.0M
Margins · last 8Q
Gross
59.9%
Operating
-122.9%
Profit
-101.7%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Ladenburg Thalmann · May 13, 2026
vs Industry
How NMTC stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.